EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

A systematic review and meta-analysis of steroid use for treatment of TB meningitis

M J Nasiri, G Hamzelouee, M Rezaeinasab, H Souri, E Eghbal, N Ghafari, L D'Ambrosio, R Centis, V Venketaraman, G B Migliori

The International Journal of Tuberculosis and Lung Disease · 29.06.2026 · 30 (7) · 297-302

DOI: 10.5588/ijtld.25.0588 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift The International Journal of Tuberculosis and Lung Disease, erschienen am 29.06.2026. Verfasst von M J Nasiri und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Antitubercular Agents, Steroids, Tuberculosis, Meningeal. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND

TB meningitis (TBM) is the most severe form of extra-pulmonary TB. This study evaluated the efficacy and safety of adjunctive steroid therapy in TBM.





METHODS

We searched PubMed/MEDLINE, Embase, and Cochrane CENTRAL for controlled trials of steroids in TBM. Pooled risk ratios (RRs) with 95% confidence intervals (CIs) were calculated for mortality, neurological complications, functional recovery, and adverse events.





RESULTS

Fourteen trials with 2,028 patients were included. Steroids reduced mortality in adults (RR = 0.83; 95% CI: 0.72–0.95) but not in children (RR = 0.68; 95% CI: 0.36–1.29). No significant benefit was seen for neurological complications (RR = 1.03; 95% CI: 0.74–1.44) or functional recovery (RR = 1.16; 95% CI: 0.86–1.57). Results were consistent across steroid types, doses, and routes.





CONCLUSION

Adjunctive steroids reduce mortality in adult TBM but not in children, nor do they improve neurological or functional outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antitubercular AgentsSteroidsTuberculosis, MeningealAdultChildHumansOdds RatioRecovery of FunctionTreatment Outcome

Substanzen

Antitubercular AgentsSteroids

Autor:innen und Institutionen

  • Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Yazd Cardiovascular Research Center, Non-communicable Diseases Research Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
  • Public Health Consulting Group, Lugano, Switzerland.
  • Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy.
  • College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA, USA.

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Nasiri, M. J., Hamzelouee, G., Rezaeinasab, M., Souri, H., Eghbal, E., Ghafari, N., D'Ambrosio, L., Centis, R., Venketaraman, V., & Migliori, G. B. (2026). A systematic review and meta-analysis of steroid use for treatment of TB meningitis. The International Journal of Tuberculosis and Lung Disease, 30(7), 297-302. https://doi.org/10.5588/ijtld.25.0588

Vancouver

Nasiri MJ, Hamzelouee G, Rezaeinasab M, Souri H, Eghbal E, Ghafari N, et al. A systematic review and meta-analysis of steroid use for treatment of TB meningitis. The International Journal of Tuberculosis and Lung Disease. 2026;30(7):297-302. doi:10.5588/ijtld.25.0588

BibTeX
@article{Nasiri2026,
  author = {Nasiri, M J and Hamzelouee, G and Rezaeinasab, M and Souri, H and Eghbal, E and Ghafari, N and D'Ambrosio, L and Centis, R and Venketaraman, V and Migliori, G B},
  title = {A systematic review and meta-analysis of steroid use for treatment of TB meningitis},
  journal = {The International Journal of Tuberculosis and Lung Disease},
  year = {2026},
  volume = {30},
  number = {7},
  pages = {297--302},
  doi = {10.5588/ijtld.25.0588}
}
Kostenlos starten →